LADENBURG THALMANN FINANCIAL SERVICES INC. - GENOMIC HEALTH INC ownership

GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 126 filers reported holding GENOMIC HEALTH INC in Q1 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of GENOMIC HEALTH INC
ValueSharesWeighting
Q3 2019$165,000
-14.1%
2,435
-26.2%
0.00%0.0%
Q2 2019$192,000
-6.8%
3,301
+12.7%
0.00%
-50.0%
Q1 2019$206,000
+23.4%
2,929
+12.6%
0.00%0.0%
Q4 2018$167,000
+28.5%
2,602
+40.7%
0.00%
+100.0%
Q3 2018$130,000
+188.9%
1,849
+30.3%
0.00%
Q2 2018$45,0000.0%1,4190.0%0.00%
Q1 2018$45,000
-29.7%
1,419
-23.2%
0.00%
-100.0%
Q4 2017$64,000
+42.2%
1,848
+31.6%
0.00%
Q3 2017$45,000
-11.8%
1,404
-9.4%
0.00%
-100.0%
Q2 2017$51,000
+8.5%
1,550
+4.3%
0.00%0.0%
Q1 2017$47,000
+9.3%
1,486
+2.3%
0.00%0.0%
Q4 2016$43,000
+22.9%
1,453
+19.4%
0.00%0.0%
Q3 2016$35,0000.0%1,217
-10.1%
0.00%0.0%
Q2 2016$35,000
+20.7%
1,353
+15.1%
0.00%0.0%
Q1 2016$29,000
-29.3%
1,175
+0.2%
0.00%0.0%
Q4 2015$41,000
+41.4%
1,173
-13.6%
0.00%0.0%
Q3 2015$29,000
-21.6%
1,358
+1.1%
0.00%0.0%
Q2 2015$37,000
-7.5%
1,343
+1.4%
0.00%0.0%
Q1 2015$40,000
-4.8%
1,325
+1.5%
0.00%0.0%
Q4 2014$42,000
+13.5%
1,3060.0%0.00%0.0%
Q3 2014$37,000
+131.2%
1,306
+117.3%
0.00%
Q2 2014$16,000
+100.0%
601
+100.3%
0.00%
Q1 2014$8,000
-61.9%
300
-59.1%
0.00%
-100.0%
Q4 2013$21,000
-4.5%
7340.0%0.00%0.0%
Q3 2013$22,000
-4.3%
7340.0%0.00%0.0%
Q2 2013$23,0007340.00%
Other shareholders
GENOMIC HEALTH INC shareholders Q1 2017
NameSharesValueWeighting ↓
Baker Brothers Advisors 13,668,866$353,955,0003.71%
Camber Capital Management LP 2,458,100$63,652,0003.08%
Ghost Tree Capital, LLC 200,000$5,179,0001.50%
Tributary Capital Management, LLC 206,291$5,342,0000.78%
Motley Fool Asset Management LLC 131,935$3,416,0000.74%
CORRADO ADVISORS, LLC 40,695$1,054,0000.68%
Broadfin Capital, LLC 270,400$7,002,0000.68%
ACUTA CAPITAL PARTNERS, LLC 48,800$1,264,0000.61%
Motley Fool Wealth Management, LLC 123,018$3,186,0000.35%
TFS CAPITAL LLC 61,773$1,600,0000.29%
View complete list of GENOMIC HEALTH INC shareholders